Pharma

Century Therapeutics Stages Highest Single Day Move In 11 Months As Casdin Capital Bumps Its Stake To 5.4%
Elon Musk And Joe Rogan Criticize Psychedelics And Big Pharma's Legacy Of Profit Over Public Health
April Showers On Wall Street: Miners, Utilities Emerge As Bright Spots In Gloomy Market
Elon Musk And Joe Rogan Criticize Psychedelics And Big Pharma's Legacy Of Profit Over Public Health
April Showers On Wall Street: Miners, Utilities Emerge As Bright Spots In Gloomy Market
Pharma's Post-Pandemic Story To Unlock A Cancer-Free Era
Beyond Tech And AI: Why The Sector Hedge Funds Prefer Is Not The One You'd Expect

Pharma Recent News

Johnson & Johnson Lost Its Court Battle But Won The Q2 Match
Last Thursday, Johnson & Johnson (NASDAQ: JNJ) has topped earnings estimates and uplifted its full-year guidance on the back of a strong medtech sales momentum.
How Technology And Economic Uncertainty Is Impacting The Life Sciences
By Lisa Om, VP of product marketing at USDM Life Sciences
5 Biotech Stocks That Could Soar Thanks To These Disruptive Healthcare Technologies
Burning Rock Narrows Losses With Drug Research As New Driver
Key Takeaways: Burning Rock’s net loss narrowed 29% to 185 million yuan in the first quarter from the same period a year earlier, helped by lower R&D and sales expenses Revenues from R&D services for drug companies more than doubled, becoming the company’s latest growth engine By Molly Wen
This 12% Dividend Yield Stock Is Set For Payout On Tuesday: What Else To Watch Out For
MediPharm Labs Debuts On US Pharmaceutical Market With Submission Of FDA DMF
CBD-based pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) has completed a Drug Master File (DMF) process for CBD Active Pharmaceutical Ingredient (API) for the US Federal Drug Administration (FDA).
Pharma, Biotech Stocks Start Week With A Bang After Biogen's Alzheimer's Approval
If you’re reading this, then apparently you weren’t affected by a global internet outage that hit many news websites. The outage appeared to hurt stock futures overnight, but things recovered to flat in the hours right before the open. 
After FDA Rejects Acadia Dementia Drug, Analysts Lament Lack Of Near-term Stock Drivers
ACADIA Pharmaceuticals Inc.
Morphic Holding IPO: What You Need To Know
BridgeBio Pharma IPO: What You Need To Know
Merck Signs Versum Buyout Deal; Entegris Receives Termination Payment
Morgan Stanley: Veeva Systems' Share Price Fails To Reflect Growth, Margin Potential
Analyst: Radius Health Could Advance 50% With Osteoporosis Treatment, Breast Cancer Pipeline
Barclays Injects Allergan With An Upgrade, Says Valuation Model Has Improved
A Survey Of Celgene's M&A Strategy
Argus Shares Eli Lilly's Optimism, Upgrades To Buy
10 Biotech Stocks Moving From ASH 2017
What If Trump Keeps Badmouthing Drug Pricing?
JPMorgan's Take On Big Pharma's New ASCO Abstracts
Not All Of Clinton's Policies Are Bad For Pharmaceuticals
Eli Lilly Discontinues Evacetrapib; Investors Move Bets To Alternatives
5-Star Biotech Stock Watch: Synta Pharmaceuticals
Takeover Whispers Add To Achillion Pharmaceuticals' Momentum

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved